The radiation protection regulations from the International Commission for Radiological Protection (ICRP) set the limit for occupational exposure to 20 mSv per year of effective dose, averaged over a defined period of 5 years (100 mSv in 5 year), with no yearly dose exceeding 50 mSv (200)
However, if side effects persist or become severe, it is essential to seek medical advice promptly
A: SEMALIX 3 TABLET are not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia type 2 (MEN2), type 1 diabetes, or a history of diabetic ketoacidosis
The 30mg vial is the most versatile option
Primary care has an extended time of 180 days and a phased approach to person eligibility
Our guide on GLP-1 maintenance dosing explores this approach in detail